Dr. Hasan Iftikhar, MD

Dr. Iftikhar practices at Augusta Health in Fishersville, Virginia, part of Augusta Health Care.

Dr. Iftikhar's NPI, 1407231152, was assigned on July 23, 2015. Dr. Iftikhar holds Virginia license 0101268237.

Dr. Iftikhar's primary practice is Augusta Health, at 78 Medical Center Drive, Fishersville, VA 22939 in Augusta County. The practice phone is (540) 332-4000.

Dr. Iftikhar's primary practice is Augusta Health in Fishersville, Virginia, part of Augusta Health Care. Dr. Iftikhar is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Iftikhar to 3 more hospitals, 4 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iftikhar practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Iftikhar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Iftikhar is licensed in Virginia.

CMS data shows 136 Medicare services from Dr. Iftikhar across 3 procedure codes in 2024, for 49 Medicare patients. Medicare paid $32,084 for them. Every service was in an office.

CMS counts 49 Medicare patients who saw Dr. Iftikhar in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 6.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iftikhar's median patient age at 67, with 51% women.

In 2024, Dr. Iftikhar wrote 330 Medicare Part D claims for 98 patients. 74% of them were for generic drugs. CMS names the drug for 165 of them, across 8 drugs with 11 or more claims each, at $32,897 in total drug cost. In 2023, CMS named 1,424 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Iftikhar for performance year 2024, reported as part of a group. Dr. Iftikhar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Iftikhar, published from 2016 to 2023. 2017 was the busiest year, with 3. Dr. Iftikhar has published most often in Cureus. Dr. Iftikhar's most frequent co-authors are Fasil Mengistu Tiruneh, MD, Daniel Asah Larbi, MD and Adebayo Christian Atanda, MD.

CMS Open Payments shows 15 general payments to Dr. Iftikhar from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $194.